PeƱaflor, Elizabeth C.
HRN: 04-54-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFTAZIDIME 1GM (VIAL)
07/09/2023
07/15/2023
IVT
1g
Q8
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes